Access Bio, Inc. (KOSDAQ:950130)

Access Bio Statistics

Total Valuation

Access Bio has a market cap or net worth of KRW 122.58 billion. The enterprise value is -236.27 billion.

Market Cap	122.58B
Enterprise Value	-236.27B

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Access Bio has 35.17 million shares outstanding. The number of shares has increased by 41.84% in one year.

Current Share Class	n/a
Shares Outstanding	35.17M
Shares Change (YoY)	+41.84%
Shares Change (QoQ)	+3.36%
Owned by Insiders (%)	0.44%
Owned by Institutions (%)	0.31%
Float	25.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.92
PB Ratio	0.22
P/TBV Ratio	0.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	2.88
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	7.63

Financial Position

The company has a current ratio of 17.42, with a Debt / Equity ratio of 0.08.

Current Ratio	17.42
Quick Ratio	16.37
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	-1.38
Interest Coverage	-27.67

Financial Efficiency

Return on equity (ROE) is -13.72% and return on invested capital (ROIC) is -28.61%.

Return on Equity (ROE)	-13.72%
Return on Assets (ROA)	-5.95%
Return on Invested Capital (ROIC)	-28.61%
Return on Capital Employed (ROCE)	-11.01%
Weighted Average Cost of Capital (WACC)	5.48%
Revenue Per Employee	309.46M
Profits Per Employee	-813.05M
Employee Count	101
Asset Turnover	0.05
Inventory Turnover	3.28

Taxes

Income Tax	-22.31B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.51% in the last 52 weeks. The beta is 0.30, so Access Bio's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	-32.51%
50-Day Moving Average	3,132.50
200-Day Moving Average	4,149.88
Relative Strength Index (RSI)	55.79
Average Volume (20 Days)	277,667

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Access Bio had revenue of KRW 31.26 billion and -82.12 billion in losses. Loss per share was -2,332.00.

Revenue	31.26B
Gross Profit	-24.77B
Operating Income	-64.19B
Pretax Income	-105.38B
Net Income	-82.12B
EBITDA	-47.03B
EBIT	-64.19B
Loss Per Share	-2,332.00

Balance Sheet

The company has 403.00 billion in cash and 42.84 billion in debt, with a net cash position of 360.15 billion or 10,239.23 per share.

Cash & Cash Equivalents	403.00B
Total Debt	42.84B
Net Cash	360.15B
Net Cash Per Share	10,239.23
Equity (Book Value)	558.49B
Book Value Per Share	15,486.20
Working Capital	408.41B

Cash Flow

In the last 12 months, operating cash flow was -29.18 billion and capital expenditures -1.79 billion, giving a free cash flow of -30.97 billion.

Operating Cash Flow	-29.18B
Capital Expenditures	-1.79B
Depreciation & Amortization	17.16B
Net Borrowing	-4.87B
Free Cash Flow	-30.97B
FCF Per Share	-880.61

Margins

Gross margin is -79.24%, with operating and profit margins of -205.39% and -262.74%.

Gross Margin	-79.24%
Operating Margin	-205.39%
Pretax Margin	-337.16%
Profit Margin	-262.74%
EBITDA Margin	-150.48%
EBIT Margin	-205.39%
FCF Margin	n/a

Dividends & Yields

Access Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-41.84%
Shareholder Yield	-41.84%
Earnings Yield	-66.99%
FCF Yield	-25.27%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Access Bio has an Altman Z-Score of 3.88 and a Piotroski F-Score of 2.

Altman Z-Score	3.88
Piotroski F-Score	2